Pages that link to "Q30369819"

The following pages link to The role of microbiota and probiotics in stress-induced gastro-intestinal damage. (Q30369819):

Displaying 50 items.

• The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions (Q26745700) (← links)
• Role of the normal gut microbiota (Q26798294) (← links)
• The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts (Q26823347) (← links)
• The Microbiome and Sustainable Healthcare (Q28088606) (← links)
• The gut microbiota--masters of host development and physiology (Q28286102) (← links)
• Gut Microbiota in Health and Disease (Q29616812) (← links)
• A novel role for maternal stress and microbial transmission in early life programming and neurodevelopment (Q30394981) (← links)
• 'Gut health': a new objective in medicine? (Q33845395) (← links)
• Beyond bacteria: a study of the enteric microbial consortium in extremely low birth weight infants (Q34102894) (← links)
• Probiotics to improve outcomes of colic in the community: protocol for the Baby Biotics randomised controlled trial (Q34396355) (← links)
• The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism (Q34448291) (← links)
• Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects (Q34624664) (← links)
• The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis (Q34955775) (← links)
• The impact of diet and lifestyle on gut microbiota and human health (Q35003717) (← links)
• Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders (Q35142420) (← links)
• Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi (Q35277854) (← links)
• Contribution of microbiota to the intestinal physicochemical barrier (Q35292478) (← links)
• Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases (Q35472040) (← links)
• The potential role of probiotics in the management of childhood autism spectrum disorders. (Q35494817) (← links)
• Perinatal programming of asthma: the role of gut microbiota (Q35550818) (← links)
• Gastroenterology issues in schizophrenia: why the gut matters (Q35577667) (← links)
• Early life microbial colonization of the gut and intestinal development differ between genetically divergent broiler lines (Q35643422) (← links)
• Urinary Metabolite Markers of Precocious Puberty (Q35722258) (← links)
• Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis (Q35824828) (← links)
• The Jekyll-and-Hyde chemistry of Phaeobacter gallaeciensis (Q36036305) (← links)
• Microbiotal-Host Interactions and Hypertension. (Q36345318) (← links)
• c-Jun NH2-terminal kinase-2 mediates osmotic stress-induced tight junction disruption in the intestinal epithelium. (Q37174638) (← links)
• Lifestyle and geographic insights into the distinct gut microbiota in elderly women from two different geographic locations (Q37494244) (← links)
• Untargeted metabolomics of colonic digests reveals kynurenine pathway metabolites, dityrosine and 3-dehydroxycarnitine as red versus white meat discriminating metabolites (Q37640243) (← links)
• Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function (Q37642855) (← links)
• Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial (Q37678784) (← links)
• Maternal separation as a model of brain–gut axis dysfunction (Q37795656) (← links)
• Metagenomic Analysis of the Dynamic Changes in the Gut Microbiome of the Participants of the MARS-500 Experiment, Simulating Long Term Space Flight (Q38451699) (← links)
• The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors (Q38653409) (← links)
• The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders (Q38955820) (← links)
• Irritable bowel syndrome: a gut microbiota-related disorder? (Q39018403) (← links)
• Impact of human aging and modern lifestyle on gut microbiota. (Q39085785) (← links)
• The Elevated Rate of Cesarean Section and Its Contribution to Non-Communicable Chronic Diseases in Latin America: The Growing Involvement of the Microbiota. (Q41471255) (← links)
• Alterations in content and localization of defensins in rat ileum and jejunum following ischemia-reperfusion. Specific peptides, in specific places, for specific jobs? (Q41823732) (← links)
• Effects of FR-91 on immune cells from healthy individuals and from patients with non-Hodgkin lymphoma (Q42682967) (← links)
• Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice (Q42684907) (← links)
• Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. (Q45760347) (← links)
• Probiotics can alleviate cardiopulmonary bypass-induced intestinal mucosa damage in rats (Q46083282) (← links)
• Stress & the gut-brain axis: Regulation by the microbiome (Q47096228) (← links)
• Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches. (Q47818880) (← links)
• Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis (Q48001906) (← links)
• Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome? (Q54258759) (← links)
• Seasonality of the gut microbiota of free-ranging white-faced capuchins in a tropical dry forest (Q57094367) (← links)
• A correlation between intestinal microbiota dysbiosis and osteoarthritis (Q60910257) (← links)
• Gut Microbiota as a Prospective Therapeutic Target for Curcumin: A Review of Mutual Influence (Q60952883) (← links)